6-cyclylmethyland 6-alkylmethyl-substituted pyrazolopyrimidines

Details for Australian Patent Application No. 2004235915 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Van Der Staay, Franz-Josef; Heckroth, Heike; Erb, Christina; Hendrix, Martin; Tersteegen, Adrian; Hafner, FrankThorsten; Van Kampen, Marja; Barfacker, Lars; Karthaus, Dagmar

Agent Davies Collison Cave

Pub. Number AU-B-2004235915

PCT Pub. Number WO2004/099211

Priority 103 36 183.9 07.08.03 DE; 103 20 784.8 09.05.03 DE; 10 2004 004 142.3 28.01.04 DE

Filing date 28 April 2004

Wipo publication date 18 November 2004

Acceptance publication date 5 August 2010

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/099211 Priority application(s): WO2004/099211

19 April 2007 Assignment before Grant

  Bayer Healthcare AG The application has been assigned to Boehringer Ingelheim International GmbH

5 August 2010 Application Accepted

  Published as AU-B-2004235915

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235923-Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists

2004235914-Transparent polypropylene containers for packaging shoes